Literature DB >> 29528779

Differential mRNA expression of inflammasome genes NLRP1 and NLRP3 in abdominal aneurysmal and occlusive aortic disease.

Carmen Gonzalez-Hidalgo1, Joaquin De Haro1, Silvia Bleda2, Cristina Cañibano1, Ignacio Michel1, Francisco Acin1.   

Abstract

NLRP1 and NLRP3 inflammasomes might differentially mediate the chronic inflammatory response in abdominal aortic aneurysm (AAA) and aortic occlusive disease (AOD). We measure differential relative gene expression of NLRP1 and NLRP3 inflammasomes in aortic tissues from 30 patients undergoing AAA open repair compared to aortic biopsies from 30 patients undergoing surgery to treat AOD. Aortic wall samples from autopsy without aortic disease were used as controls. NLRP3 was overexpressed in patients with AAA and AOD (RQ 1.185 ± 0.15, and 1.098 ± 0.05, respectively) compared to donors (RQ 1.001 ± 0.08) (OR 2.8, 95% CI 1.2-4.3, p < 0.05 for AAA and OR 2.1, 95% CI 1.1-3.8, p < 0.05 for AOD). NLRP1 gene expression was significantly upregulated in patients with AOD (RQ 1.197 ± 0.09). Meanwhile, NLRP1 was normal expressed in AAA (RQ 1.003 ± 0.07) as well as in autopsy aortic specimens (RQ 1.005 ± 0.11). Enhanced NLRP1 expression in AOD was even significant when compared to AAA (OR 2.3, 95% CI 1.2-3.3, p < 0.05) or controls (OR 2.2, 95% CI 1.1-3.1, p < 0.05). According to our findings, NLRP3 could be involved in the common etiology of AAA and AOD, whereas NLRP1 appears to have a specific role in AOD development.

Entities:  

Keywords:  NLRP1; NLRP3; abdominal aortic aneurysm; aortic occlusive disease; inflammasomes

Mesh:

Substances:

Year:  2018        PMID: 29528779      PMCID: PMC5941670          DOI: 10.1177/1753944717750338

Source DB:  PubMed          Journal:  Ther Adv Cardiovasc Dis        ISSN: 1753-9447


  28 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  NLRP1 inflammasome, and not NLRP3, is the key in the shift to proinflammatory state on endothelial cells in peripheral arterial disease.

Authors:  Silvia Bleda; Joaquin de Haro; Cesar Varela; Leticia Esparza; Antonio Ferruelo; Francisco Acin
Journal:  Int J Cardiol       Date:  2014-01-09       Impact factor: 4.164

3.  Increased expression and activation of absent in melanoma 2 inflammasome components in lymphocytic infiltrates of abdominal aortic aneurysms.

Authors:  Susanne Dihlmann; Philipp Erhart; Arianeb Mehrabi; Arash Nickkholgh; Felix Lasitschka; Dittmar Böckler; Maani Hakimi
Journal:  Mol Med       Date:  2014-06-19       Impact factor: 6.354

Review 4.  The immune response in atherosclerosis: a double-edged sword.

Authors:  Göran K Hansson; Peter Libby
Journal:  Nat Rev Immunol       Date:  2006-06-16       Impact factor: 53.106

5.  Inflammasome activation by mitochondrial oxidative stress in macrophages leads to the development of angiotensin II-induced aortic aneurysm.

Authors:  Fumitake Usui; Koumei Shirasuna; Hiroaki Kimura; Kazuki Tatsumi; Akira Kawashima; Tadayoshi Karasawa; Koichi Yoshimura; Hiroki Aoki; Hiroko Tsutsui; Tetsuo Noda; Junji Sagara; Shun'ichiro Taniguchi; Masafumi Takahashi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-11-06       Impact factor: 8.311

Review 6.  Sterile inflammation: sensing and reacting to damage.

Authors:  Grace Y Chen; Gabriel Nuñez
Journal:  Nat Rev Immunol       Date:  2010-11-19       Impact factor: 53.106

Review 7.  Current status of medical management for abdominal aortic aneurysm.

Authors:  Jonathan Golledge; Paul E Norman
Journal:  Atherosclerosis       Date:  2011-03-10       Impact factor: 5.162

Review 8.  The autoimmune origin of atherosclerosis.

Authors:  Claudio Blasi
Journal:  Atherosclerosis       Date:  2008-05-23       Impact factor: 5.162

9.  Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation.

Authors:  William F Johnston; Morgan Salmon; Gang Su; Guanyi Lu; Matthew L Stone; Yunge Zhao; Gary K Owens; Gilbert R Upchurch; Gorav Ailawadi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-03       Impact factor: 8.311

Review 10.  Inflammation and cellular immune responses in abdominal aortic aneurysms.

Authors:  Koichi Shimizu; Richard N Mitchell; Peter Libby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-02-23       Impact factor: 8.311

View more
  6 in total

1.  Mean Platelet Volume-to-Platelet Count Ratio, Mean Platelet Volume-to-Lymphocyte Ratio, and Red Blood Cell Distribution Width-Platelet Count Ratio as Markers of Inflammation in Patients with Ascending Thoracic Aortic Aneurysm.

Authors:  Yusuf Kenan Tekin; Gülacan Tekin
Journal:  Braz J Cardiovasc Surg       Date:  2020-04-01

Review 2.  Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective.

Authors:  Santosh V Suryavanshi; Igor Kovalchuk; Olga Kovalchuk
Journal:  Front Immunol       Date:  2021-01-28       Impact factor: 7.561

3.  Inflammasome Targeted Therapy as Novel Treatment Option for Aortic Aneurysms and Dissections: A Systematic Review of the Preclinical Evidence.

Authors:  Markus Wortmann; Rosa Klotz; Eva Kalkum; Susanne Dihlmann; Dittmar Böckler; Andreas S Peters
Journal:  Front Cardiovasc Med       Date:  2022-01-20

4.  Colchicine Does Not Reduce Abdominal Aortic Aneurysm Growth in a Mouse Model.

Authors:  James Phie; Shivshankar Thanigaimani; Pacific Huynh; Raghuveeran Anbalagan; Corey S Moran; Robert Kinobe; Joseph V Moxon; Matt A Field; Smriti M Krishna; Jonathan Golledge
Journal:  Cardiovasc Ther       Date:  2022-09-30       Impact factor: 3.368

Review 5.  Importance of NLRP3 Inflammasome in Abdominal Aortic Aneurysms.

Authors:  Jinyun Shi; Jia Guo; Zhidong Li; Baohui Xu; Masaaki Miyata
Journal:  J Atheroscler Thromb       Date:  2021-03-06       Impact factor: 4.928

6.  Characterization of CD4+ T Cell Subsets in Patients with Abdominal Aortic Aneurysms.

Authors:  Fábio Haach Téo; Rômulo Tadeu Dias de Oliveira; Liana Villarejos; Ronei Luciano Mamoni; Albina Altemani; Fabio Husemann Menezes; Maria Heloisa Souza Lima Blotta
Journal:  Mediators Inflamm       Date:  2018-12-27       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.